Efficacy and Safety Study of BOTOX Compared to Topiramate for the Prevention of Chronic Migraine in Adults
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Botulinum toxin A (Primary) ; Topiramate
- Indications Migraine
- Focus Therapeutic Use
- Acronyms FORWARD
- Sponsors Allergan
- 10 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 13 Jul 2016 Planned number of patients changed from 400 to 280.
- 13 Jul 2016 Planned End Date changed from 1 Aug 2017 to 1 Sep 2017.